Endovia Health Sciences Inc EDVA

Morningstar Rating
$0.14 −0.00 (0.49%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EDVA is trading at a LOCK|$BBq> premium.
Price
$0.14
Fair Value
LOCK|^GH^j!
Uncertainty
LOCK|mt d?<t$
1-Star Price
LOCK|>hg&lDV
5-Star Price
LOCK|nbX&J&
Economic Moat
LOCK|@<hkK
Capital Allocation
—

Trading Information

Previous Close Price
$0.14
Day Range
$0.14–0.15
52-Week Range
$0.13–6.76
Bid/Ask
$0.14 / $0.17
Shares Outstanding
11.41M
Market Cap
$1.64M
Volume/Avg
265,045 / 3M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
47.08
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
3

Valuation

Metric
EDVA
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
47.08
Price/Cash Flow
—
Price/Earnings
EDVA

Financial Strength

Metric
EDVA
Quick Ratio
0.02
Current Ratio
0.05
Interest Coverage
−5.29
Quick Ratio
EDVA

Profitability

Metric
EDVA
Return on Assets (Normalized)
−62.20%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
EDVA

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|D>%w&p$LOCK|>d^YW$131B
Regeneron Pharmaceuticals Inc
REGN
LOCK|F&??%yLOCK|#byF$95B
Moderna Inc
MRNA
LOCK|c^DdYw%LOCK|^Z$79B
argenx SE ADR
ARGX
LOCK|#VmrHS^LOCK|s&$59B
BeOne Medicines Ltd ADR
ONC
LOCK|&!%$#?#LOCK|Wc%$45B
Royalty Pharma PLC Class A
RPRX
LOCK|Lf<FgM$RLOCK|?h^$h$30B
Incyte Corp
INCY
LOCK|^>$&tbLOCK|w>^$23B
BioNTech SE ADR
BNTX
LOCK|&ks$SbQLOCK|z^$20B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|X!w%<cLLOCK|!b^r$19B
BridgeBio Pharma Inc
BBIO
LOCK|%QXY&RLOCK|>M$15B

Sponsor Center